# Comparison of Clopidogrel-based Antiplatelet Agent Treatment and Aspirin Plus Low Dose Rivaroxaban Therapy

Study · id `cardio:ct-nct07796217` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07796217](<https://clinicaltrials.gov/study/NCT07796217>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT07796217

Browse, organ or system: Heart; Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 2758 participants.

## Technical summary

Registry record NCT07796217. Randomized; no masking; primary purpose prevention. Start 2023-11-15 (actual); primary completion 2027-06-30 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose prevention
- Phase: Phase 4
- Enrolled: 2758 participants (planned count; ClinicalTrials.gov record NCT07796217, source copy `cardio:ctgov-nct07796217-2026-09-02`, retrieved 2026-10-26)
- Started: 2023-11-15 (actual) (ClinicalTrials.gov record NCT07796217, source copy `cardio:ctgov-nct07796217-2026-09-02`, retrieved 2026-10-26)
- Primary completion: 2027-06-30 (anticipated) (ClinicalTrials.gov record NCT07796217, source copy `cardio:ctgov-nct07796217-2026-09-02`, retrieved 2026-10-26)
- Completion: 2027-12-31 (anticipated) (ClinicalTrials.gov record NCT07796217, source copy `cardio:ctgov-nct07796217-2026-09-02`, retrieved 2026-10-26)
- Countries: South Korea (ClinicalTrials.gov record NCT07796217, source copy `cardio:ctgov-nct07796217-2026-09-02`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07796217-2026-09-02`, retrieved 2026-10-26)

## The registry's words

- Brief title: Comparison of Clopidogrel-based Antiplatelet Agent Treatment and Aspirin Plus Low Dose Rivaroxaban Therapy
- Acronym: OACART
- Condition: Cardiac Event
- Condition: Coronary Artery Disease
- Condition: Peripheral Artery Disease
- Condition: Bleeding
- Intervention (Drug): Aspirin and low-dose rivaroxaban
- Intervention (Drug): Clopidogrel with or without aspirin
- Lead sponsor: Seoul National University Bundang Hospital
- Lead sponsor class: OTHER
- Collaborator: Korea University Guro Hospital
- Collaborator class: OTHER
- Collaborator: Korea University Ansan Hospital
- Collaborator class: OTHER
- Collaborator: Korea University Anam Hospital
- Collaborator class: OTHER
- Collaborator: Chungnam National University Sejong Hospital
- Collaborator class: OTHER
- Collaborator: National Health Insurance Service Ilsan Hospital
- Collaborator class: OTHER
- Collaborator: Ewha Womans University Seoul Hospital
- Collaborator class: OTHER
- Collaborator: Konyang University Hospital
- Collaborator class: OTHER
- Collaborator: Seoul National University Hospital
- Collaborator class: OTHER
- Collaborator: KangWon National University Hospital
- Collaborator class: OTHER
- Collaborator: Sejong General Hospital
- Collaborator class: OTHER
- Collaborator: Inha University Hospital
- Collaborator class: OTHER
- Collaborator: Severance Hospital
- Collaborator class: OTHER
- Collaborator: Myongji Hospital
- Collaborator class: OTHER
- Collaborator: Chonnam National University Hospital
- Collaborator class: OTHER
- Collaborator: Chungnam National University Hospital
- Collaborator class: OTHER
- Collaborator: Jeju National University Hospital
- Collaborator class: OTHER
- Collaborator: Kwangju christian hospital
- Collaborator class: UNKNOWN
- Collaborator: Soonchunhyang University Hospital
- Collaborator class: OTHER
- Collaborator: Wonju Severance Christian Hospital
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry condition terms include this condition: Peripheral artery disease (`cardio:peripheral-artery-disease`)

## Registry records

Records a program assembled from a public registry; no person wrote or checked them. They are counted here, not listed: the JSON record of this page lists each one in its relationships.

- 17 registry organizations

## Provenance

Content hash: c5ebe94dce6d4eaf6daf5518e2d561b9deb9effb905b015e5b10350bae1976ca
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
